Why Bristol-Myers Squibb Stock Gained 13% in October
Biopharma titan Bristol-Myers Squibb (NYSE: BMY) saw its shares gain 13% in October, according to data from S&P Global Market Intelligence.
What sparked this sizable rally in the drugmaker's shares last month? For most of the month, Bristol's stock simply drifted higher in tandem with the broader markets -- fueled by the dual prospects of an end to the trade war with China and the enactment of far more modest reforms toward branded drug pricing in the United States than those originally proposed by some Democrats.
Image source: Getty Images.
Source Fool.com
